PROX1 and neoplasm: Additional reports, focusing specifically on the contribution of BMDCs of the myeloid lineage to tumor lymphangiogenesis, examined also PROX1 expression (Zumsteg et al., 2009; Volk-Draper et al., 2017, 2019).